FDA Inspection 902499 — Nageshwara Arvind Dasari, MD

Nageshwara Arvind Dasari, MD — FEI 3011022459

The FDA completed an inspection of Nageshwara Arvind Dasari, MD on November 7, 2014 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 7, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756221 CFR 312.60Informed consent